seript of the human c-myc gene (H c-myc), we.show that the mouse c-myc (M c-myc) gene is contained. within NLARD. NIARD-associated chromosome translocations occurred 1.3-2 kilobases (kb) 5' of the mouse c-myc gene where NIARD Non-immunoglobulin-associated rearranging DNA (NIARD) is a unique DNA sequence in the mouse genome that has recently been shown to generate aberrantly rearranged Cat immunoglobulin genes in various BALB/c plasmacytomas (1) (2) (3) . The NIARD sequence recombines with the switch (S) region of the C,, gene but does not have any striking sequence homology with it (refs. 1-3; unpublished data). NZB plasmacytomas appear to prefer rearranging NIARD outside of the CH gene locus (1) . NIARD rearrangements were not observed in the normal B- lymphocyte genome (1) (2) (3) and appear to be rare events in T-cell lymphomas and other neoplastic cells not of B-lymphocyte origin (refs. 1-3; unpublished data). NIARD has been localized to chromosome 15 (2, 4) and is associated with a specific chromosome translocation [T (12; 15) ] (1, 4) which is frequently observed in plasmacytomas (5) (6) (7) . A similar type of translocation event is associated with Burkitt lymphomas (8, 9) wherein the distal end ofchromosome 8 translocates to the heavy chain locus residing on chromosome 14 (10, 11) . Interestingly, the human cellular analogue of the v-myc oncogene of the avian retrovirus has recently been localized to the distal end of human chromosome 8 (12) .
In this report, we demonstrate that (i) NIARD contains the mouse analogue of the MC-29 oncogene (c-myc); (ii) increased amounts of structurally different mouse c-myc (i.e., NIARD) transcripts are produced in plasmacytomas compared to normal mouse spleen; (iii) human c-myc and NIARD probes detect human c-myc DNA rearrangements in Burkitt lymphomas and some of these appear to result from chromosome 8 translocations to the C,, immunoglobulin locus on chromosome 14 (12) .
MATERIALS AND METHODS RNA Isolation. Total poly(A)+RNA and membrane bound polysomal poly(A)+RNA were isolated from plasmacytomas and cultured myeloma cells essentially as described (13, 14) . BALB/c spleen and liver total poly(A)'RNAs were prepared by extraction in guanidinium thiocyanate and phenol at 650C as described (15) .
Hybridizations. Filters for Southern hybridizations were prepared as described by Southern (16) . For genomic DNA blot hybridizations, filters were prehybridized in 5x standard saline citrate (NaCI/Cit; lx is 0.15 M NaCl/0.015 M Na citrate)/5X Denhardt solution (0.1% polyvinylpyrrolidone/0. 1% Ficoll/ 0.1% bovine serum albumin)/50% deionized formamide/5 mM EDTA/0.2% NaDodSO4 at 420C for 4 hr. Hybridizations were performed in5X NaCl/Cit containing, 10% dextran sulfate, lx Denhardt solution, 25 mM Na Pi (pH 6.5), 0.2% NaDodSO4, 40% deionized formamide, 5 mM EDTA, salmon sperm DNA at 50 ug/ml, poly(rA) at 10 ug/ml, and label equivalent to 1-2 X 106 cpm/ml for 16-24 hr at 40-440C. Filters were washed twice at 55-580C for 1 hr in 0.2 X NaCl/Cit containing 0.2% NaDodSO4 except where indicated and exposed to x-ray film with an intensifier screen.
RNAs were denatured at 650C for 10 min in 50% formamide/ 2 mM Mops [ (3-(N-morpholino) propanesulfonic acid]/50 mM NaOAc/10 mM EDTA, pH 7.0 (Mops buffer) and applied to a 1% agarose gel prepared in 6% formaldehyde/Mops buffer; they were transferred to nitrocellulose essentially as described by Thomas (17) . Prehybridization and hybridization procedures were performed essentially as described above for genomic Southern blots. Single-stranded DNA hybridization probes were prepared in M13 phage vectors mp8 and mp9 essentially as described by Hu and Messing (18) .
Abbreviation: NIARD, non-immunoglobulin-associated rearranging DNA; S region, switch region; NaCI/Cit, standard saline citrate; bp, base pair(s); kb, kilobase(s).
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (1, 3) and two other IgA-producing myelomas (M167 and M603) (2) are shown in Fig. 1A . Studies on a larger panel of IgA-and non-IgA-producing plasmacytomas indicated that all retain the NIARD BamHI site immediately 5' of the S. sequence in J558 a4 (Fig. 1A) (Fig. 2 ). These and other mapping studies located the pRyc-7.4 hybridizing sequence within NIARD (Fig. 1A) . The NIARD EDTA, salmon sperm DNA at 50 ttg/ml, poly(rA) at 10 pLg/ml, and 0.1% NaDodSO4 with -1 x 105 cpm of nick-translated pRyc-7.4 per ml ("1.5 x 108 cpm/ml). The filter was subsequently washed for 1 hr in two changes of 0.lx NaCl/Cit containing 0.1% NaDodSO4 at 600C, blotted dry, and autoradiographed for 36 hr with an intensifier screen. appeared to contain the entire mouse c-myc hybridizing sequence. Cleavage with Sst I separated the pRyc-7.4 hybridizing region into two bands ofdifferent intensities ( Figs. 1 and 2 ). Pst I restriction sites appeared to be conserved at the 5' ends of both the mouse and human c-myc genes (Fig. 1) .
The c-myc gene is not perfectly conserved in mouse and man. The intensity ofhybridization ofpRyc-7.4 to NIARD decreased with filter washes at higher stringency (i.e., 50-550C to 60-65°C) (data not shown). The human c-myc gene [==3.3 kilobases (kb)] has been shown to possess two similar sized exons (-=750 bp each) separated by a "'1.8-kb intron (19) . The mouse c-myc gene within our NIARD sequence appeared to be no more than 2.4 kb long. This conclusion is based in part on the complete absence of hybridization ofthe pRyc-7.4 probe beyond the Xho I site at the 3' end of pa25BH3.4. This would define the end of the 3' exon as being no further than this Xho I site. By comparison to a human c-myc genomic clone (19), the 5' end of the mouse c-myc gene within NIARD is tentatively localized to two Pst I restriction sites which appear to be conserved at the 5' end ofboth mouse and human c-myc genes (Fig. 1) . The assignment of the mouse c-myc 5' end is also in agreement with blotting experiments performed with plasmacytoma poly(A)+RNAs (see below). The mouse c-myc gene, residing in the translocated NIARD sequence may have a smaller intron than the human c-myc. gene but proof of-this idea requires more confirmation.
Activation of NIARD Transcripts in Plasmacytomas. RNA blots were performed to identify NIARD-(i.e., mouse c-myc) Total cell poly(A)+ and membrane-bound polysome poly(A)+ RNAs were isolated from these four plasmacytomas and total poly(A)+RNA was prepared from BALB/c spleen and liver. RNA blotting results with total poly(A)+RNA from plasmacytomas were identical to data obtained with poly(A)+RNAs isolated from polyribosomes. The polysomal poly(A)+RNAs were =3-fold purified relative to total cell poly(A)+RNAs (13, 14) . Hybridization results obtained with nitrocellulose filter blots of formaldehyde/agarose gel-fractionated, formamide-denatured poly(A)+RNAs to pa25BH3.4 (NIARD probe) and pRyc-7.4 (human c-myc probe) are shown in Fig. 3 . NIARD (mouse c-myc) and human c-myc probes detected identical-sized poly(A)+RNA species; low levels of a 2.3-kb mouse c-myc (i.e., NIARD) transcript were present in spleen and liver. The HeLa cell c-myc transcript was slightly smaller than the normal mouse NIARD transcript (i.e., =2.15 kb compared to =2.3 kb). Increased amounts (10-to 20-fold) of NIARD transcripts (i.e., mouse c-myc) appeared in all four plasmacytomas tested. Plasmacytomas that had a NIARD rearrangement (with or without S,) contained new transcripts 1.8-2.1 kb long. PC 3741 (which displays no obvious NIARD rearrangement) contained a 2.3-kb NIARD transcript and a =2.15-kb transcript that migrated with the HeLa cell c-myc transcript.
NIARD and C. Are Transcribed from Opposite DNA Strands. As indicated in Fig. 1 , the mouse c-myc gene within NIARD is oriented opposite to the direction of the Ca coding region. In order to confirm this result and to estimate the limits of the NIARD (mouse c-myc) transcripts, we prepared singlestranded DNA probes in M13 phage cloning vehicles for RNA (Fig. 1) by differential splicing because of the following. (i) Several Pst I sites within the 3.4-kb BamHI-HindIII fragment also were observed at the 5' end of the 5' human c-myc exon (19) (Fig. 1) , suggesting that the entire mouse c-myc encoding region is within this 3.4-kb DNA fragment. (iii) The NIARD recombination sites in M167 and M603 are considerably 5' of the J558 rearrangement site (2) (Fig. 1) Context of the Human c-myc Gene in Burkitt Lymphoma. The human c-myc gene has been observed to translocate along with the distal end of chromosome 8 to the human heavy chain immunoglobulin gene locus on chromosome 14 (12) . Therefore, we investigated whether DNA rearrangement events occur in close proximity to the human c-myc gene in a panel of Burkitt lymphomas. Fig. 5 displays two Southern blots of BALB/c liver, human placenta, and two Burkitt lymphoma cell lines hybridized to pa25BH3.4 (NIARD probe) and pRyc-7.4 (human c-myc probe). These results are summarized as follows. (i) NIARD and human c-myc uniquely detect each other in their corresponding genomes. (ii) The human c-myc gene displays an altered context in both Burkitt DNA samples. Because human contextual differences also could be due to genetic polymorphisms, we analyzed a larger panel of Burkitt cell lines. We could detect c-myc rearrangements in only two (CA46 and JD381V) of the five additional Burkitt lymphoma cell lines (20) ; in both of these, a new 22-kb BamHI band was present (Fig.  6B) . Since BamHI cuts outside of the human c-myc gene and outside of the unrearranged human C, gene (21), we also rehybridized the same filter with a 1.2-kb EcoRI genomic probe of the C,L gene that detects the first two exons and part of the third exon of CL. The two 22-kb bands hybridized with the C probe (Fig. 6A, lanes 4 and 7) . Cleavage with HindIII and EcoRI, confirmed that, in cell lines CA46 and JD381I, the human c-myc gene translocated in close proximity to the human C,, gene (data not shown).
DISCUSSION
We have shown that the C-myc oncogene is adjacent to the site of a chromosome translocation that is commonly observed in mouse and human B-cell neoplasia. These translocations appear to be mediated by a DNA sequence originally defined as NIARD (1, 4 (19) and NIARD (1) are so indicated.
creased levels ofmouse c-myc (or NIARD) transcripts compared to normal mouse spleen cells. The actual hybridization intensity differences presented in Figs. 3 and 4 represent a 20-to 40-fold increase in NIARD transcripts. However, most plasmacytomas containing NIARD rearrangements display a slightly increased copy number of rearranged NIARD sequences compared to germ-line controls (1) (i.e., to 2-to 3-fold higher). We presume (Fig. 3D) . This result may suggest that NIARD is preferentially transcribed in lymphocytes. In addition, the level of c-myc transcripts (compared to the BALB/c spleen control) appears to be higher in mouse plasmacytomas than in HeLa cells (Fig. 3 A, C, However, this sequence environment does not appear to be obligatory for enhanced transcription of new mouse c-myc transcripts because (i) enhanced transcription of NIARD occurs in the PC 3741 plasmacytoma which displays no obvious NIARD rearrangement (1) and (ii) NIARD rearrangements need not be associated with the CH gene locus because increased levels of new transcripts are evident in MPC-11. Clearly, more refined structural work is needed to completely characterize these new transcripts and their potential role in B cell neoplasia.
In bursal lymphomas, the avian c-myc gene is activated by the integration ofan avian leukosis virus promoter (22) (23) (24) . The v-myc gene of avian myelocytomatosis virus (strain MC-29) has been found to generate foci of transformed cells when transfected into NIH 3T3 cells (25) whereas the avian c-myc gene, activated by the integration of an avian leukosis virus promoter (22) (23) (24) , does not transform NIH 3T3 cells (26) .
Preliminary results indicate that the J558 a4 genomic clone does not yield foci upon transfection into NIH 3T3 cells compared to a high level of foci observed with the cloned T24 human bladder carcinoma oncogene (ref. 27; unpublished data). Therefore, the human c-myc and mouse c-myc genes may represent a class of oncogenes that are incapable of rapid transformation of NIH-3T3 cells via DNA transfection. Further studies are obviously required to confirm and support this important observation. The increased expression or production of structurally altered c-myc gene transcripts could represent a step of a complex pathway resulting in the activation of dominant acting c-onc genes eventually yielding neoplasia. We propose that DNA sequences with properties analogous to those of NIARD exist on chromosomes other than human chromosome 8 and mouse chromosome 15 . The activation ofcellular oncogenes by a NIARD-like chromosome translocation may constitute a general mechanism of cellular neoplastic transformation.
